Quick Takeaways
- This page summarizes James E. Francese's Form 4 filing for STAAR SURGICAL CO (STAA).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 08 Mar 2022, 17:44.
James E. Francese - 07 Mar 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Signature
- /s/ Samuel Gesten as attorney-in-fact for James Francese
- Issuer symbol
- STAA
- Transactions as of
- 07 Mar 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 Mar 2022, 17:44:18 UTC
- Previous filing
- 18 Aug 2021
- Next filing
- 16 Mar 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"James E. Francese filed Form 4 for STAAR SURGICAL CO (STAA) on 08 Mar 2022."
What Changed
- Previous filing in this sequence was filed on 18 Aug 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +5,839
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 58,469
- Date
- 07 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
STAA
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- +12,146
- Change %
- Price
- $0.000000
- Shares after
- 12,146
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,146
- Exercise price
- $74.80
- Footnotes
- F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Award of 5839 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/7/23, 1/3 of the RSUs on 3/7/24, and the remaining 1/3 of the RSUs on 3/7/25. |
| F2 | The options granted become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025. |